CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L901. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9 | -96.0% | 33,000 | -38.4% | 0.00% | – |
| Q1 2023 | $225 | -53.7% | 53,600 | -33.7% | 0.00% | -100.0% |
| Q4 2022 | $486 | -98.8% | 80,900 | +1008.2% | 0.00% | – |
| Q3 2022 | $42,000 | -56.2% | 7,300 | -54.9% | 0.00% | – |
| Q2 2022 | $96,000 | +29.7% | 16,200 | +1.2% | 0.00% | – |
| Q1 2022 | $74,000 | +10.4% | 16,000 | -41.6% | 0.00% | – |
| Q4 2021 | $67,000 | -11.8% | 27,400 | -7.4% | 0.00% | – |
| Q3 2021 | $76,000 | +2.7% | 29,600 | 0.0% | 0.00% | – |
| Q2 2021 | $74,000 | +428.6% | 29,600 | +60308.2% | 0.00% | – |
| Q1 2021 | $14,000 | – | 49 | -18.3% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 60 | +233.3% | 0.00% | – |
| Q3 2020 | $3,000 | -62.5% | 18 | -76.6% | 0.00% | – |
| Q2 2020 | $8,000 | -78.9% | 77 | -68.7% | 0.00% | – |
| Q4 2019 | $38,000 | +1166.7% | 246 | +446.7% | 0.00% | – |
| Q3 2019 | $3,000 | -87.5% | 45 | -84.3% | 0.00% | – |
| Q2 2019 | $24,000 | +2300.0% | 287 | +1588.2% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 17 | +6.2% | 0.00% | – |
| Q3 2018 | $3,000 | -57.1% | 16 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | – | 16 | +60.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 10 | -99.1% | 0.00% | – |
| Q1 2017 | $2,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,800 | $19,000 | 0.00% |
| SIMPLEX TRADING, LLC | 60 | $0 | 0.00% |